Open-Label Study to Assess Meplazumab in Adult Patients Diagnosed with Plasmodium Falciparum
Open-Label Study to Assess Meplazumab in Adult Patients Diagnosed with Plasmodium Falciparum
Active, not recruiting · NCT06040346 · Registry updated 2024-10-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Open-Label Study to Assess Meplazumab in Adult Patients Diagnosed with Plasmodium Falciparum | Infections, Mosquito-Borne Diseases, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Active, not recruiting | Phase 2 | 2024-10-29 | NCT06040346 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Kisumu County Referral Hospital | Kisumu | Kenya | 1 |